A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma

Saglam, Sezer; Aykan, N.; ŞAKAR, Burak; GÜLLÜOĞLU, Mine; Balik, Emre; Karanlik, Hasan

doi:10.3978/j.issn.2078-6891.2010.030

A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma

Copy For Citation

Saglam S., Aykan N. F., ŞAKAR B., GÜLLÜOĞLU M., Balik E., Karanlik H.

JOURNAL OF GASTROINTESTINAL ONCOLOGY, vol.2, no.1, pp.19-26, 2011 (SCI-Expanded)

Publication Type: Article / Article
Volume: 2 Issue: 1
Publication Date: 2011
Doi Number: 10.3978/j.issn.2078-6891.2010.030
Journal Name: JOURNAL OF GASTROINTESTINAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.19-26
Istanbul University Affiliated: Yes

Abstract

Background: Best response rates have been achieved with three-drug regimens containing 5-FU in the treatment of advanced gastric cancer (AGC) and oral fluoropyrimidines are the best alternatives as substitutes for infusional 5-FU. This study aimed to evaluate the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) regimens in AGC outpatients.